LifeMap Sciences Announces Release And Commercial Availability Of Geneanalytics™ 1.0, A Powerful Gene Set Analysis Tool Powered By Genecards®, Lifemap Discovery® And Malacards
ALAMEDA, Calif.--(BUSINESS WIRE)--LifeMap Sciences, Inc., a subsidiary of BioTime, Inc., announced today the commercial release of GeneAnalytics 1.0 at www.geneanalytics.com. GeneAnalytics™ is a powerful, yet easy to use, gene set analysis tool designed to help life scientists and biomedical researchers identify expression signatures and functionality of their experimental gene sets, and define their roles in various biological processes and in health and disease.
GeneAnalytics™ is powered by LifeMap Sciences’ popular integrated knowledgebase and discovery platform for biomedical research, which includes: GeneCards® (http://www.genecards.org), the human gene database, LifeMap Discovery® (http://discovery.lifemapsc.com), the embryonic development and stem cell database and MalaCards (http://www.malacards.org), the human disease database. LifeMap Sciences holds the exclusive worldwide license to market GeneCards® and MalaCards from Yeda Research and Development Company Ltd., the commercial arm of the Weizmann Institute of Science.
Help employers find you! Check out all the jobs and post your resume.
GeneAnalytics™ is powered by LifeMap Sciences’ popular integrated knowledgebase and discovery platform for biomedical research, which includes: GeneCards® (http://www.genecards.org), the human gene database, LifeMap Discovery® (http://discovery.lifemapsc.com), the embryonic development and stem cell database and MalaCards (http://www.malacards.org), the human disease database. LifeMap Sciences holds the exclusive worldwide license to market GeneCards® and MalaCards from Yeda Research and Development Company Ltd., the commercial arm of the Weizmann Institute of Science.
Help employers find you! Check out all the jobs and post your resume.